Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.390 |
None |
0.778 |
9 |
1
|
2003 |
2018 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.330 |
None |
1.000 |
3 |
|
2005 |
2008 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.320 |
None |
1.000 |
3 |
|
2008 |
2010 |
Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1180
|
140
|
0.310 |
None |
1.000 |
3 |
|
2008 |
2010 |
Schizophrenia and related disorders
|
group |
Mental Disorders
|
Disease or Syndrome
|
20
|
5
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2010 |
Toxic Encephalitis
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Encephalopathy, Toxic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
98
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Thrombus
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
46
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Neurotoxicity Syndromes
|
group |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
34
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Essential Hypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
445
|
293
|
0.300 |
None |
|
0 |
|
|
|
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.200 |
None |
1.000 |
2 |
|
2006 |
2014 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
420
|
15
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Nephrosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
68
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.947 |
19 |
1
|
1979 |
2018 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.100 |
None |
0.778 |
18 |
1
|
2003 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.941 |
17 |
1
|
1979 |
2018 |